PLERIXAFOR INJECTION
PLERIXAFOR INJECTION
Approved
DIN Number
02490846
Drug Class
Human
Market Date
N/A
Company
HC
fresenius kabi canada ltd
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02490846
AIG Number0153050001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L03AX16 PLERIXAFOR
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification20:16.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
PLERIXAFORActive
Strength: 20 MG / ML
Monograph: PLERIXAFOR